Baidu
map

Science采用改进CRISPR技术 发现近500个新的lncRNAs

2016-12-20 生物通/万纹 生物通/万纹

长链非编码RNA (lncRNAs)是一类长度大约为200个核苷酸,但不编码任何蛋白的神秘分子,一直以来科学家们都想知道基因组中这类分子到底是起什么作用的。12月15日Science杂志公布了一项最新研究发现:来自加州大学旧金山分校的研究人员识别出了499个新lncRNAs,这为理解这些小分子的功能奠定了基础。同时研究人员也发现lncRNAs与大多数编码基因不同,后者能作用于多种细胞系,但令人惊讶


长链非编码RNA (lncRNAs)是一类长度大约为200个核苷酸,但不编码任何蛋白的神秘分子,一直以来科学家们都想知道基因组中这类分子到底是起什么作用的。

12月15日Science杂志公布了一项最新研究发现:来自加州大学旧金山分校的研究人员识别出了499个新lncRNAs,这为理解这些小分子的功能奠定了基础。同时研究人员也发现lncRNAs与大多数编码基因不同,后者能作用于多种细胞系,但令人惊讶的是,90%已发现的lncRNAs只会影响一种细胞类型的生长。

“大多数细胞中都具有大量的lncRNAs这种神秘分子,但我们不知道它们具体有多少,哪些对基本生物功能具有重要意义。这项最新成果让我们惊讶的是,大多数lncRNAs只在一种细胞类型内发挥功能,这种RNA功能的极度特异性是之前未曾发现过的,”文章作者,加州大学旧金山分校神经学家和临床医师 Daniel Lim说。

之前的研究表明,某些lncRNAs 在细胞生长和功能,以及疾病发生过程中扮演了关键角色,十年前科学家们发现人体基因组中很大一部分是转录成了lncRNAs,一些研究组指出几十个lncRNAs对细胞,甚至机体来说具有重要意义。但只有少数研究发现了lncRNAs的功能,这受限于分析lncRNAs功能和作用细胞类型的研究工具。

在最新这项研究中,研究人员采用了非常热门的一项新工具:CRISPR技术,研发了一种CRISPR干扰平台(CRISPRi),靶向七种不同细胞系中16,401个lncRNAs,这七种细胞系包括六种转化细胞系,和一种人诱导多能干细胞系。研究人员利用CRISPRi工具,抑制了每种候选lncRNA,这样筛选了上千个位点,从中找到了499个细胞强健生长所必需的位点,而其中89%只作用于一种细胞类型。

“这种技术的力量来自CRISPRi,是它帮助我们能关闭这些非编码转录子的转录,”Lim说。为了能确保CRISPRi快速筛选顺利进行,研究人员也为每个位点准备了10个导向RNA,从而构建了大约包含170,000个导向RNAs的文库,研究人员将这个文库命名为 CRiNCL (CRISPRi noncoding library),由Addgene提供。

不过这项研究中最令人惊奇的发现,就是绝大多数的lncRNA基因只作用于一种细胞类型的细胞生长。蛋白编码基因在许多类型细胞中发挥着关键的作用,但lncRNAs只在一种细胞中扮演重要角色,这说明lncRNAs给每个细胞注明了身份。

一些科学家对这一研究盛赞,指出这是第一次通过特殊细胞类型全基因组筛选lncRNA,从中我们可以断定大多数lncRNAs对于细胞活力至关重要,之前这一观点还被质疑,现在得到了证实。

不过目前尚不清楚这499个lncRNAs位点如何影响细胞生长,这一研究克服了全基因组筛选的许多不足之处,但不能判断到底是这些lncRNAs转录的作用,还是最终RNA产物的作用。

同时这项研究也将对靶向癌症治疗产生影响,研究证明了许多lncRNAs位点在细胞增殖过程中具有重要意义,那么在癌症等需要细胞增殖的疾病中,这些位点就代表着以RNA为基础的新型治疗途径。

原始出处

S. John Liu1,2,*, Max A. Horlbeck3,4,5,6,*, Seung Woo Cho9.et.al.CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells.Science  15 Dec 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1935533, encodeId=32541935533fa, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Mar 21 22:19:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005418, encodeId=52ef200541890, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Fri Mar 10 17:19:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005629, encodeId=f8e420056295f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Sat Oct 07 00:19:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275973, encodeId=9b9312e5973c0, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301856, encodeId=e6cd1301856c8, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375426, encodeId=c78713e5426bb, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618698, encodeId=44fe16186980d, content=<a href='/topic/show?id=e798524076' target=_blank style='color:#2F92EE;'>#Crispr技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5240, encryptionId=e798524076, topicName=Crispr技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a49419938232, createdName=ms1779634646866130, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1935533, encodeId=32541935533fa, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Mar 21 22:19:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005418, encodeId=52ef200541890, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Fri Mar 10 17:19:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005629, encodeId=f8e420056295f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Sat Oct 07 00:19:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275973, encodeId=9b9312e5973c0, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301856, encodeId=e6cd1301856c8, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375426, encodeId=c78713e5426bb, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618698, encodeId=44fe16186980d, content=<a href='/topic/show?id=e798524076' target=_blank style='color:#2F92EE;'>#Crispr技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5240, encryptionId=e798524076, topicName=Crispr技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a49419938232, createdName=ms1779634646866130, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
    2017-03-10 dzx0922889
  3. [GetPortalCommentsPageByObjectIdResponse(id=1935533, encodeId=32541935533fa, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Mar 21 22:19:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005418, encodeId=52ef200541890, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Fri Mar 10 17:19:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005629, encodeId=f8e420056295f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Sat Oct 07 00:19:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275973, encodeId=9b9312e5973c0, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301856, encodeId=e6cd1301856c8, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375426, encodeId=c78713e5426bb, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618698, encodeId=44fe16186980d, content=<a href='/topic/show?id=e798524076' target=_blank style='color:#2F92EE;'>#Crispr技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5240, encryptionId=e798524076, topicName=Crispr技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a49419938232, createdName=ms1779634646866130, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1935533, encodeId=32541935533fa, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Mar 21 22:19:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005418, encodeId=52ef200541890, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Fri Mar 10 17:19:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005629, encodeId=f8e420056295f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Sat Oct 07 00:19:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275973, encodeId=9b9312e5973c0, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301856, encodeId=e6cd1301856c8, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375426, encodeId=c78713e5426bb, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618698, encodeId=44fe16186980d, content=<a href='/topic/show?id=e798524076' target=_blank style='color:#2F92EE;'>#Crispr技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5240, encryptionId=e798524076, topicName=Crispr技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a49419938232, createdName=ms1779634646866130, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
    2016-12-22 yuandd
  5. [GetPortalCommentsPageByObjectIdResponse(id=1935533, encodeId=32541935533fa, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Mar 21 22:19:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005418, encodeId=52ef200541890, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Fri Mar 10 17:19:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005629, encodeId=f8e420056295f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Sat Oct 07 00:19:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275973, encodeId=9b9312e5973c0, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301856, encodeId=e6cd1301856c8, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375426, encodeId=c78713e5426bb, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618698, encodeId=44fe16186980d, content=<a href='/topic/show?id=e798524076' target=_blank style='color:#2F92EE;'>#Crispr技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5240, encryptionId=e798524076, topicName=Crispr技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a49419938232, createdName=ms1779634646866130, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
    2016-12-22 xzw113
  6. [GetPortalCommentsPageByObjectIdResponse(id=1935533, encodeId=32541935533fa, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Mar 21 22:19:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005418, encodeId=52ef200541890, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Fri Mar 10 17:19:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005629, encodeId=f8e420056295f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Sat Oct 07 00:19:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275973, encodeId=9b9312e5973c0, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301856, encodeId=e6cd1301856c8, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375426, encodeId=c78713e5426bb, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618698, encodeId=44fe16186980d, content=<a href='/topic/show?id=e798524076' target=_blank style='color:#2F92EE;'>#Crispr技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5240, encryptionId=e798524076, topicName=Crispr技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a49419938232, createdName=ms1779634646866130, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
    2016-12-22 jichang
  7. [GetPortalCommentsPageByObjectIdResponse(id=1935533, encodeId=32541935533fa, content=<a href='/topic/show?id=5d67109e9d7' target=_blank style='color:#2F92EE;'>#lncRNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10979, encryptionId=5d67109e9d7, topicName=lncRNAs)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606c2500035, createdName=ms3153534357578991, createdTime=Tue Mar 21 22:19:00 CST 2017, time=2017-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005418, encodeId=52ef200541890, content=<a href='/topic/show?id=d09f155461e' target=_blank style='color:#2F92EE;'>#RNAs#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15546, encryptionId=d09f155461e, topicName=RNAs)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Fri Mar 10 17:19:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005629, encodeId=f8e420056295f, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Sat Oct 07 00:19:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275973, encodeId=9b9312e5973c0, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5211, encryptionId=755d5211a0, topicName=CRISPR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301856, encodeId=e6cd1301856c8, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375426, encodeId=c78713e5426bb, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618698, encodeId=44fe16186980d, content=<a href='/topic/show?id=e798524076' target=_blank style='color:#2F92EE;'>#Crispr技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5240, encryptionId=e798524076, topicName=Crispr技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a49419938232, createdName=ms1779634646866130, createdTime=Thu Dec 22 14:19:00 CST 2016, time=2016-12-22, status=1, ipAttribution=)]

相关资讯

Nature:CRISPR技术背后的无名英雄们

CRISPR技术大热,成就了一大波学术明星。但这些学术大牛们的研究生和博后们的贡献往往会被忽略。 当Blake Wiedenheft开始学习微生物时,他的工作颇有些不切实际,前途不明。 他的博士生涯主要是对国家黄石公园的温泉进行取样,然后人工仿造温泉中的微生物。 Wiedenheft指出,他们想知道,这些微生物是如何在高温、强酸的环境中生存的。 随着时间的推移,Wiedenheft对微生

如何利用基因魔剪—CRISPR技术来进行非编码基因组功能的研究?

我们或许才刚刚开始打开对巨大的基因组非编码区域的研究,基于CRISPR的两项新技术或许就能够帮我们开启研究的新篇章。我们(原文笔者)能够很好地理解基因组中编码蛋白组分背后的规则,同时通过对DNA序列的观察我们也能够找出从事编码作用的基因的开始以及终止位置。 对于基因组中残留的98%的基因组而言,却又是一番不同的故事了,如今我们对于DNA暗物质的理解都是来自于对非编码DNA单个

CRISPR不是张锋的?基因编辑工具的专利之争

从2012年开始,CRISPR/Cas9被用于很多生物系统中进行基因组编辑,在各大顶级期刊上发表了大量文章,可算是赚足了眼球。随着CRISPR/Cas9基因编辑系统逐渐进化,并趋于成熟,从学术界的共享走向专利申请以及商业化的道路也逐渐清晰起来。然而面前还存在着很多问题,例如,CRISPR/Cas9的专利申请之路就并不那么顺利。 CRISPR/Cas9是什么? CRISPR/Cas9,是

Science:CRISPR先驱发表新成果!

来自加州大学伯克利分校、德国马克斯普朗克生物物理化学研究所的研究人员揭示出了为识别靶DNA,预先组织形成的一种Cas9-导向RNA(gRNA)复合物的构象。这项研究发布在近期的《科学》(Science)杂志上。文章的通讯作者是加州大学伯克利分校的Jennifer A. Doudna博士。Doudna是CRISPR技术的共同开发者,曾因这一技术获得了“生命科学突破奖”(Breakthrough Pr

盘点:2015年基因编辑领域重磅级研究TOP10

2015年12月1-3日,在华盛顿特区召开了一次大型国际会议,人类基因组编辑的伦理学将会再次成为召开的一个的主题。这次峰会将由美国国家科学院、美国国家医学科学院、中国科学院和英国皇家学会联合组织,这次会议中各国研究人员还将对人类的基因组编辑的众多问题进行讨论;那么在即将过去的2015年里,基因编辑领域有哪些亮点研究呢?请看2015年基因编辑领域研究TOP10。

MIT:CRISPR技术再升级,走入精准控制时代

如果说到近几年来生物学领域取得的重大突破,或许很多人都会提到CRISPR。作为一项极具潜力的基因编辑技术,CRISPR不但在新药研发的高通量筛选过程中扮演了越来越重要的角色,更有直接应用于临床的能力——今年6月,美国NIH下属的重组DNA咨询委员会投票一致通过CRISPR可用于人体基因编辑。而在7月,四川大学华西医院的科学家也宣布将把CRISPR技术应用于人体,以期治疗非小细胞肺癌。不难想象,未来

Baidu
map
Baidu
map
Baidu
map